dDuring a 14-month period of using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for group B streptococcus (GBS) identification, we recovered 32 (1%) Streptococcus pseudoporcinus isolates from 3,276 GBS screening cultures from female genital sources (25 isolates from pregnant women and 7 from nonpregnant women). An additional two S. pseudoporcinus isolates were identified from a urine culture and a posthysterectomy wound culture. These isolates were found to cross-react with three different GBS antigen agglutination kits, PathoDx (Remel) (93%), Prolex (Pro-Lab Diagnostics) (38%), and Streptex (Remel) (53%). New approaches to bacterial identification in routine clinical microbiology laboratories may affect the prevalence of S. pseudoporcinus.
Streptococcus pseudoporcinus is a beta-hemolytic Gram-positive coccus that was identified as a separate and independent Streptococcus species in 2006 (1). S. pseudoporcinus has been isolated from the female genitourinary tract and has biochemical characteristics similar to those of Streptococcus agalactiae, which is also known as group B streptococcus (GBS) (1-3). The prevalence and clinical significance of genitourinary S. pseudoporcinus and its relationship to peripartum neonatal and maternal infections are not currently known (2, 3). In 2011, Stoner et al. (4) sought to identify the prevalence and epidemiology of S. pseudoporcinus in the genital tracts of nonpregnant women. They found that 5.4% of the women in their study had genital cultures positive for this bacterium. The cross-reactivity of standard GBS testing kits raises concerns that S. pseudoporcinus has been misidentified as GBS in routine GBS screening cultures (1-4). In addition, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis is coming to be routinely used for organism identification (5, 6). At the Johns Hopkins Hospital (JHH) microbiology laboratory, we became aware of S. pseudoporcinus identification from positive GBS screening cultures after the implementation of MALDI-TOF MS (Bruker Daltonics, Billerica, MA) for organism identification. Thus, we prospectively identified S. pseudoporcinus isolates from GBS screening cultures to determine the prevalence and clinical characteristics of patients with S. pseudoporcinus colonization.(Some of the data in this paper were presented in poster form at the 115th General Meeting of the American Society for Microbiology, 30 May to 2 June 2015, New Orleans, LA.)We identified S. pseudoporcinus and S. agalactiae from GBS screening cultures at the JHH between 1 April 2014 and 31 May 2015. Swabs from female genital sources were inoculated into Todd-Hewitt (TH) broth and onto 5% sheep blood agar (SBA; Remel, Lenexa, KS) plates. The broth was incubated at 35°C in a 5% CO 2 incubator for 18 to 24 h, subcultured onto 5% SBA, and then incubated for 18 to 24 h. Beta-hemolytic colonies from GBS screening cultures were identified by MALDI-TOF MS (Bruker Microflex, Biotyper software V.3...